News

head uk2

Clinical Studies with Chitosan

Chitosan is not only used for feverish laboratory-scale research, but also for specific application in chitosan-based products for a wide variety of indications, which are being tested in clinical studies. In this article we provide an insight into current clinical studies on chitosan and present the results of two studies on chronic wound healing and improved hemostasis after puncture of the radial artery.

Currently, the website clinicaltrial.gov lists 10 clinical studies (search term chitosan) with the status “recruiting” (see table below).

Table 1: List of clinical studies containing the search term chitosan according to clinicaltrial.gov (accessed 05.03.2018).

Title Conditions Interventions Locations
Chitosan Nerv Tube for Primary Repair of Traumatic Sensory Nerve Lesions of the Hand Traumatic Lesion of Sensory Nerves of the Hand

Device: Chitosan nerve tube in addition to gold standard therapy

Procedure: Gold standard Primary
microsurgical repair

Germany
Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan (Mediclore®) Gynecologic Disease

Device: Mediclore

Device: Adept

Korea
Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients Cancer: Breakthrough Pain Cancer: Extreme Pain on Movement Drug: Morphine
Drug: Ketamine
Drug: Placebo
Drug: Chitosan
Switzerland
Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures Coronary Artery Disease Puncture Device: ezClot (hemostasis pad)
Device: BloodSTOP ix pad
Device: Rotary compression device
Korea
To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) Gynecologic Disease Device: Mediclore® (adhesion barrier) Korea
Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer Breastcancer

Surgery: Axillary Dissection

Device: adhesive barrier

Korea
Functional Chewing Gum in Reduction of Gingival Inflammation Gingivitis Device: Functional Chitosan Chewing GumDevice: Control Chewing Gum
Behavioral: Oral hygiene measures
US
Dental Extractions in Patients Under Dual Antiplatelet Therapy

Blood Coagulation Disorders

Device: HemCon Dental Dressing

Device: Oxidized Cellulose Gauze

Brazil
Nonneoplastic Epithelial Disorders of Vulva and High Intensity Focused Ultrasound Vulva Intraepithelial Nonneoplastic

Device: the high intensity focused ultrasound (Mianyang Sonic electronic LLC)

Drug: Fu Tiankang disposable vaginal filling suppository, Albothyl (Policresulen Solution) , and the gynecologic medical antimicrobial dressing gel (chitosan gel)

China
Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions Peripheral Nerve Injuries Device: Implantation Germany

Below we present the results of two completed chitosan-related studies.

Chitosan has promising properties in treatment of chronic wounds. These kinds of wounds are highly problematic for patients and very expensive for the health care system. Pressure ulcers are a common kind of chronic wound, with mainly bedridden people being affected. A large number of studies already reported that chitosan is excellent for wound treatment. The following clinical study deals with the treatment of such chronic wounds using chitosan.

Chitosan Gel to Treat Pressure Ulcers: A Clinical Pilot Study

Campani V., Pagnozzi E., Mataro I., Mayol L., Perna A., D´Urso F., Carillo A., Cammarota M., Maiuri M.C., De Rosa G. Pharmaceutics.10 (1). pii: E15. doi: 10.3390/pharmaceutics10010015. January 2018

They reported a clinical study on 20 patients with pressure ulcers and treated with Chitosan (viscosity >400 mPas) gel prepared in the hospital. In the study, the efficacy and the tolerability of the treatment were evaluated.

For the study, a number of patients between 40-80 years were enrolled in the study over 30 days. Lesions were cleaned with povidone iodine solution and physiological solution. The whole area of the decubitus ulcer was coated with Chitosan gel and covered with a secondary dressing. The dressing was renewed two times a week in an outpatient clinic. Each time the area of the skin lesion was measured and the patients assessed their satisfaction level on a visual analogue scale (VAS) ranging from not satisfied (0) to fully satisfied (100). Reduction of the wound area by at least 20% after four weeks of treatment was chosen as endpoint. Additionally the tolerability of the Chitosan gel was investigated.

Results after 4 week treatment with Chitosan gels:

  • Significant reduction (>20%) of wound area for most patients (90%)
  • For 20% of patients the lesion was completely healed
  • For 50% of cases a reduction of 50% was reached

Conclusion: The study showed the efficacy of Chitosan gel in improving wound healing. For the majority of patients enrolled in the study, lesion area was significantly reduced. As the next step, the effect of the Chitosan gel needs to be demonstrated with a larger number of study participants to confirm results of the presented study. On-site preparation of the chitosan gel makes the device cost-efficiently and a promising approach for the treatment of pressure ulcers.

Source: http://www.mdpi.com/1999-4923/10/1/15

We continue with the following exciting study:

Hemostasis pad combined with compression device after transradial coronary procedures: A randomized controlled trial.

Kang S.H., Han D., Kim S., Yonn C.H., Park J.J., Suh J.W., Cho Y.S., Youn T.J., Chae I.H. PLoS One. 2017 Jul 24, 12(7):e0181099. Doi: 10.1371/journal.pone.0181099. eCollection 2017.

Coronary angiography is used for diagnosis of coronary arteries. This procedure is performed by getting access to the arterial system from femoral artery or radial artery in the wrist. The radial access has many advantages, but complications such as severe bleeding at the injection site or vascular occlusion are still possible. In order to reduce these, effective and successful hemostasis is particularly important. To stop the bleeding, compression devices or hemostasis pads are often used. The clinical study investigated whether the combinded use of chitosan-based pads and a compression device improved the efficacy of hemostasis after transradial coronary angiography compared to the sole use of the compression device.

The non-blinded study was performed at a single study center. The patients who underwent coronary angiography with transradial approach were randomly assigned to a study group (compression device with or without chitosan-based wound dressing). A 4 month study with 95 participants, thereof 59 in treatment group (rotatory compression device plus hemostasis pad) and 36 in control group (rotatory compression device alone) was performed. The primary endpoint of the study was hemostasis (Categories: ≤5, 6-10, 11-20, and >20 minutes).

Results

  • Significant reduced hemostasis time in treatment group compared to control group
  • Occurrence of vascular complications was low for both groups

Limitations of the study are the small number of patients and the lack of long-term assessment of the vascular access site, e.g. with ultrasound.

Conclusion: Study results indicate that the additional application of chitosan based pads with a compression device is a promising approach for treatment of puncture site after radial artery access.

Source: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181099

chitosan, Clinical Studies Chitosan, Hemostasis, wound treatment, chitosan gel

Congress and fairs

Meet us in person 2024:

  • 14th PBP World Meeting/ Research Pharm, Vienna, Austria, 18.-21.03.2024
  • CPHI, Milan, Italy, 08.-10.10.2024
  • MEDICA 2024, Düsseldorf, Germany, 11.-14.11.2024

To arrange an appointment please contact Katja Richter via This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • This email address is being protected from spambots. You need JavaScript enabled to view it.
Contact | GTC / Terms of Use | Legal info | Copyright © 2024 Heppe Medical Chitosan GmbH | Privacy notice

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.